General information
Muenchensteinerstrasse 38
4002 Basel, Basle-City (BS)

Contact person: Max Bayer, Program Manager
Company main phone: +41 (61) 3168111
Company main fax:  +41 (61) 3169111
Website:  http://www.lonza.com
Source of foundation:Subsidiary
Name of foundation source:Lonza AG
Corporate description / mission:
Lonza operates as a partner to the pharmaceutical, biotech and nutrition markets. The company provides contract development and manufacturing services that enable pharma and biotech companies to bring medicines to patients in need. The company offers a wide range of services and products from early phase discovery to custom development and manufacturing of active pharmaceutical ingredients to innovative dosage forms for the pharma and consumer health and nutrition industries.
State of ownership: Subsidiary
Headquarters: No
  • Biotechnology - R&D Services
  • Analytical services
  • CMO (Contract Manufacturing Organization)
  • Fill & finish
  • Synthesis services
Primary therapeutic areas:
  • Cardiovascular / cardiology
  • Digestive system / gastroenterology
  • Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
  • Diseases of the eye / ophthalmology
  • Diseases of the nervous system / neurology
  • Endocrine, nutritional and metabolic diseases / endocrinology
  • Infectious and parasitic diseases / infectiology / parasitology
  • Mental and behavioural disorders / psychiatry /psychology
  • Musculoskeletal system and connective tissue / Orthopedics
  • Neoplasms / cancer / oncology
  • Pregnancy, childbirth and the puerperium / obstetrics
  • Respiratory / pulmonology
  • Skin and subcutaneous tissue / dermatology
Business model:
  • Manufacturer
  • R&D
  • Service company
  • Subsidiary
Customer segments:
  • Large biotech & big pharma
  • Small biotech
  • Direct (own sales force)